L. Renee Ruhaak

Papers

Total Citations

H-Index

About

L. Renee Ruhaak is a leading figure in clinical proteomics and mass spectrometry, whose work bridges the gap between cutting-edge analytical technology and unmet medical needs. Her research focuses on developing quantitative protein mass spectrometry (MS) tests for precision diagnostics, with a particular emphasis on translating these tools from the lab bench to routine clinical use. In her highly cited 2021 paper, "The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs" (46 citations), Ruhaak compellingly argues that MS-based quantification—unlike traditional immunoassays—offers direct, multiplexed detection of proteoforms, making it ideal for precision medicine. This work underscores her major contribution: championing MS as a transformative platform for clinical diagnostics. Beyond this landmark paper, her broader portfolio of highly cited studies has shaped how researchers approach protein quantification, earning her recognition as a thought leader in the field. Ruhaak’s impact is evident in the growing adoption of MS-based tests she has helped pioneer, and her advocacy continues to inspire students and researchers to embrace quantitative proteomics for solving real-world clinical challenges.